Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xiujuan Tan, Chunfeng Liu & Lingling Sun. (2023) Association between CTLA4 + 49A/G polymorphism and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Nucleosides, Nucleotides & Nucleic Acids 0:0, pages 1-14.
Read now
Read now
Dimitrios Papaconstantinou, D. Brock Hewitt, Zachary J. Brown, Dimitrios Schizas, Diamantis I. Tsilimigras & Timothy M. Pawlik. (2022) Patient stratification in hepatocellular carcinoma: impact on choice of therapy. Expert Review of Anticancer Therapy 22:3, pages 297-306.
Read now
Read now
Articles from other publishers (23)
M. Ahmad, Y. Hameed, M. Khan, M Usman, A. Rehman, U. Abid, R. Asif, H. Ahmed, M. S. Hussain, J. U. Rehman, H. M. Asif, R. Arshad, M. Atif, A. Hadi, U. Sarfraz & U. Khurshid. (2024) Up-regulation of GINS1 highlighted a good diagnostic and prognostic potential of survival in three different subtypes of human cancer. Brazilian Journal of Biology 84.
Crossref
Crossref
Ninghua Yao, Wei Jiang, Yilang Wang, Qianqian Song, Xiaolei Cao, Wenjie Zheng & Jie Zhang. (2023) An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma. European Journal of Medical Research 28:1.
Crossref
Crossref
Darmadi Darmadi, Riska Habriel Ruslie & Cennikon Pakpahan. (2022) Association between serum midkine levels and tumor size in Indonesian hepatocellular carcinoma patients: a cross-sectional study. Romanian Journal of Internal Medicine 60:4, pages 229-234.
Crossref
Crossref
Yi Shi, Jingrui Men, Hongliang Sun & Jianjun Tan. (2022) The Identification and Analysis of MicroRNAs Combined Biomarkers for
Hepatocellular Carcinoma Diagnosis. Medicinal Chemistry 18:10, pages 1073-1085.
Crossref
Crossref
Ishfaq Hassan Mir, K. C. Jyothi & Chinnasamy Thirunavukkarasu. (2021) The prominence of potential biomarkers in the diagnosis and management of hepatocellular carcinoma: Current scenario and future anticipation. Journal of Cellular Biochemistry 123:10, pages 1607-1623.
Crossref
Crossref
Yu Zhong, Hong Huo, Shuqi Dai & Su Li. (2022) Efficacy and safety of immune checkpoint inhibitors-combined antiangiogenic drugs in the treatment of hepatocellular carcinoma: A systematic review and meta analysis. Frontiers in Oncology 12.
Crossref
Crossref
Jingbo Chen, Xingte Chen, Ting Li, Lei Wang & Guishan Lin. (2022) Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response. International Immunopharmacology 109, pages 108866.
Crossref
Crossref
Xiongdong Zhong, Xianchang Yu & Hao Chang. (2022) Exploration of a Novel Prognostic Nomogram and Diagnostic Biomarkers Based on the Activity Variations of Hallmark Gene Sets in Hepatocellular Carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Danijel Galun, Dragana Mijac, Aleksandar Filipovic, Aleksandar Bogdanovic, Marko Zivanovic & Dragan Masulovic. (2022) Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective. Journal of Personalized Medicine 12:2, pages 149.
Crossref
Crossref
Muhammad Usman & Yasir Hameed. (2022) GNB1, a novel diagnostic and prognostic potential biomarker of head and neck and liver hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 0:0, pages 0.
Crossref
Crossref
S Pilar Zamora-León. (2021) Hepatocellular carcinoma biomarkers, an imminent need. World Journal of Gastrointestinal Oncology 13:11, pages 1847-1849.
Crossref
Crossref
Maoye Wang, Jianmei Gu, Xu Zhang, Jianping Yang, Xiaoxin Zhang & Xinjian Fang. (2021) Long Non-coding RNA DANCR in Cancer: Roles, Mechanisms, and Implications. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Jing Wu, Ran Xue, Rong-Tao Jiang & Qing-Hua Meng. (2021) Characterization of metabolic landscape in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 13:9, pages 1144-1156.
Crossref
Crossref
Lazaro Hiram Betancourt, Jeovanis Gil, Yonghyo Kim, Viktória Doma, Uğur Çakır, Aniel Sanchez, Jimmy Rodriguez Murillo, Magdalena Kuras, Indira Pla Parada, Yutaka Sugihara, Roger Appelqvist, Elisabet Wieslander, Charlotte Welinder, Erika Velasquez, Natália Pinto de Almeida, Nicole Woldmar, Matilda Marko‐Varga, Krzysztof Pawłowski, Jonatan Eriksson, Beáta Szeitz, Bo Baldetorp, Christian Ingvar, Håkan Olsson, Lotta Lundgren, Henrik Lindberg, Henriett Oskolas, Boram Lee, Ethan Berge, Marie Sjögren, Carina Eriksson, Dasol Kim, Ho Jeong Kwon, Beatrice Knudsen, Melinda Rezeli, Runyu Hong, Peter Horvatovich, Tasso Miliotis, Toshihide Nishimura, Harubumi Kato, Erik Steinfelder, Madalina Oppermann, Ken Miller, Francesco Florindi, Qimin Zhou, Gilberto B. Domont, Luciana Pizzatti, Fábio C. S. Nogueira, Peter Horvath, Leticia Szadai, József Tímár, Sarolta Kárpáti, A. Marcell Szász, Johan Malm, David Fenyö, Henrik Ekedahl, István Balázs Németh & György Marko‐Varga. (2021) The human melanoma proteome atlas—Defining the molecular pathology. Clinical and Translational Medicine 11:7.
Crossref
Crossref
Ting Song, Li Li, Shaobo Wu, Yan Liu, Caiping Guo, Wen Wang, Lili Dai, Tong Zhang, Hao Wu & Bin Su. (2021) Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Soumya Jogi, Radha Varanai, Sravani S. Bantu & Ashish Manne. (2020) Selecting the first line treatment in non-metastatic hepatocellular carcinoma - comparing clinical practice guidelines. Oncology Reviews 14:2.
Crossref
Crossref
Yasi Pan, Huarong Chen & Jun Yu. (2020) Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives. Biomedicines 8:12, pages 576.
Crossref
Crossref
Jiao Feng, Jingjing Li, Liwei Wu, Qiang Yu, Jie Ji, Jianye Wu, Weiqi Dai & Chuanyong Guo. (2020) Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Crossref
Xiaofei Wang, Jie Qiao & Rongqi Wang. (2020) Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma. Bioscience Reports 40:11.
Crossref
Crossref
P. Gunasekhar & S. Vijayalakshmi. (2020) Optimal biomarker selection using adaptive Social Ski-Driver optimization for liver cancer detection. Biocybernetics and Biomedical Engineering 40:4, pages 1611-1625.
Crossref
Crossref
Yan Zhao, Ya-Ni Zhang, Kai-Ting Wang & Lei Chen. (2020) Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1874:1, pages 188391.
Crossref
Crossref
Stephanie Hametner-Schreil. (2020) Immunotherapy in hepatocellular carcinoma. memo - Magazine of European Medical Oncology 13:2, pages 218-222.
Crossref
Crossref
Jingbo Chen, Xingte Chen, Ting Li, Lei Wang & Guishan Lin. (2021) Identification of Chromatin Organization-Related Gene Signature for Predicting Hepatocellular Carcinoma Prognosis and Immunotherapy Response. SSRN Electronic Journal.
Crossref
Crossref